Talecris Biotherapeutics Holdings Corp. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/11 Q1

ended 12/31/10 FY 2010

ended 09/30/10 Q3

ended 06/30/10 Q2

ended 03/31/10 Q1

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Business combination disclosure

Business combination disclosure

Ownership Filter

Ampersand 1999 LP

Charpie Richard A

Stern Lawrence D

Petteway Stephen R Jr

Perkins John R II

News Filter

Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Change of Control, Change in Directors, Officers or Compensation

Shareholder Vote Results

Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff

Announces First Quarter 2011 Results - First Quarter 2011 Revenue Increases 6.7% to $406.7 Million - - Net Income Increases 22.3% to $55.5 Million - - Reported Diluted EPS of $0.43

Proxies Filter

Definitive proxy

Proxy related to merger

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC